Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapy.
Kadokura M, Maekawa S, Sueki R, Miura M, Komase K, Shindo H, Amemiya F, Uetake T, Inoue T, Sakamoto M, Nakagawa M, Sakamoto N, Watanabe M, Enomoto N. Kadokura M, et al. Among authors: shindo h. Hepatol Int. 2011 Sep;5(3):789-99. doi: 10.1007/s12072-011-9267-x. Epub 2011 Mar 20. Hepatol Int. 2011. PMID: 21484117
Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy.
Kadokura M, Maekawa S, Sueki R, Miura M, Komase K, Shindo H, Amemiya F, Uetake T, Inoue T, Sakamoto M, Nakagawa M, Sakamoto N, Watanabe M, Enomoto N. Kadokura M, et al. Among authors: shindo h. PLoS One. 2011;6(9):e24514. doi: 10.1371/journal.pone.0024514. Epub 2011 Sep 15. PLoS One. 2011. PMID: 21935415 Free PMC article.
Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients.
Shindo H, Maekawa S, Komase K, Sueki R, Miura M, Kadokura M, Shindo K, Amemiya F, Kitamura T, Nakayama Y, Inoue T, Sakamoto M, Okada S, Asahina Y, Izumi N, Honda M, Kaneko S, Enomoto N. Shindo H, et al. Among authors: shindo k. Hepatol Int. 2012 Apr;6(2):482-90. doi: 10.1007/s12072-011-9306-7. Epub 2011 Aug 18. Hepatol Int. 2012. PMID: 22020822
Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis C.
Miura M, Maekawa S, Kadokura M, Sueki R, Komase K, Shindo H, Ohmori T, Kanayama A, Shindo K, Amemiya F, Nakayama Y, Kitamura T, Uetake T, Inoue T, Sakamoto M, Okada S, Enomoto N. Miura M, et al. Among authors: shindo h, shindo k. Hepatol Int. 2012 Jan;6(1):386-96. doi: 10.1007/s12072-011-9307-6. Epub 2011 Aug 17. Hepatol Int. 2012. PMID: 22020823
Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection.
Maekawa S, Sakamoto M, Miura M, Kadokura M, Sueki R, Komase K, Shindo H, Komatsu N, Shindo K, Kanayama A, Ohmori T, Amemiya F, Takano S, Yamaguchi T, Nakayama Y, Kitamura T, Inoue T, Okada S, Enomoto N. Maekawa S, et al. Among authors: shindo h, shindo k. Hepatology. 2012 Nov;56(5):1611-21. doi: 10.1002/hep.25826. Hepatology. 2012. PMID: 22577043
IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication.
Shindo H, Maekawa S, Komase K, Miura M, Kadokura M, Sueki R, Komatsu N, Shindo K, Amemiya F, Nakayama Y, Inoue T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N. Shindo H, et al. Among authors: shindo k. J Viral Hepat. 2013 Apr;20(4):281-9. doi: 10.1111/j.1365-2893.2012.01649.x. Epub 2012 Aug 7. J Viral Hepat. 2013. PMID: 23490373
497 results